期刊
SEMINARS IN CANCER BIOLOGY
卷 37-38, 期 -, 页码 65-76出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2015.12.003
关键词
Second malignant neoplasms; Radiotherapy; Radiation-induced bystander effect; Inflammation; Radioprotectors; Antioxidants
类别
资金
- Australian National Health and Medical Research Council (NHMRC) [10275598]
- National Institute of Health (NIH) [5U19AI067773-07]
- round of the priority-driven Collaborative Cancer Research Scheme (CCRS) - Australian Government Department of Health and Ageing (DHA) [1002743]
- Victorian Government's Operational Infrastructure Support Program
- Undergraduate Research Opportunities Program (UROP), Biomedical Research Victoria, Australia
- Sirtex Medical
- PMCC
- Cancer Australia (CA)
- NIFA [690304, 1002743] Funding Source: Federal RePORTER
This review is aimed at the issue of radiation-induced second malignant neoplasms (SMN), which has become an important problem with the increasing success of modern cancer radiotherapy (RT). It is imperative to avoid compromising the therapeutic ratio while addressing the challenge of SMN. The dilemma is illustrated by the role of reactive oxygen species in both the mechanisms of tumor cell kill and of radiation-induced carcinogenesis. We explore the literature focusing on three potential routes of amelioration to address this challenge. An obvious approach to avoiding compromise of the tumor response is the use of radioprotectors or mitigators that are selective for normal tissues. We also explore the opportunities to avoid protection of the tumor by topical/regional radioprotection of normal tissues, although this strategy limits the scope of protection. Finally, we explore the role of the bystander/abscopal phenomenon in radiation carcinogenesis, in association with the inflammatory response. Targeted and non-targeted effects of radiation are both linked to SMN through induction of DNA damage, genome instability and mutagenesis, but differences in the mechanisms and kinetics between targeted and non-targeted effects may provide opportunities to lessen SMN. The agents that could be employed to pursue each of these strategies are briefly reviewed. In many cases, the same agent has potential utility for more than one strategy. Although the parallel problem of chemotherapy-induced SMN shares common features, this review focuses on RT associated SMN. Also, we avoid the burgeoning literature on the endeavor to suppress cancer incidence by use of antioxidants and vitamins either as dietary strategies or supplementation. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据